Grants

Grants & Other Sponsored Projects

 

We're working to update the sponsored projects information that appears on this page. Please check back!

Title Principal Investigator Unitsort descending Sponsor Name
Phase III Colon Cancer Prevention Trial
Gerner,Eugene W
Cancer Center Division
University of California, Irvine
A...Study Comparing the Combination of the BRAF Inhibitor, Dabrafenib and the MEK Inhibitor, Trametinib to Dabrafenib and Placebo as First-Line ...
Cranmer,Lee D
Cancer Center Division
Glaxosmithkline
A Phase II Randomized, Double-blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide with or without Deforolimus...
Ahmann,Frederick R
Cancer Center Division
Merck and Company
Phase 3 Study of SGN-35 (brentuximab vedotin) and best supportive case (BSC)...residual Hodgkin Lymphoma (HL) following autologous stem cell...
Yeager,Andrew M
Cancer Center Division
Seattle Genetics, Incorporated
ML27763 "An open-Label Multicenter Phase II Study of Continuous Oral Vemurafenib in Patients with Metastatic Melanoma and BRAF
Hersh,Evan M
Cancer Center Division
Genetech, Incorporated
Exploration of the use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients with Diabetic F
Kuo,Phillip H
Cancer Center Division
Covance, Incorporated
A-LONG: An Open-label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant Factor VIII Fc Fusion Protein ...
Stopeck,Alison T
Cancer Center Division
Biogen Idec, Incorporated
Health-Related Quality-of-Life and Health-Care Resource Utilization Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies
Leischow,Scott J
Cancer Center Division
Nabi Biopharmaceuticals
Establishing an International Network and Regional Network of Healthcare Providers to Treat Tobacco Dependence
Leischow,Scott J
Cancer Center Division
Mayo Clinic
Regional Hemophilia Network-Mountain States
Stopeck,Alison T
Cancer Center Division
Oregon Health and Science University
Development of an Automated in situ Test to Perform Molecular Sub-classification of Prostate Cancer in Standard Prostate Biopsies
Stratton,Steven P
Cancer Center Division
Ventana Medical Systems, Inc.
A...Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFRa Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced ...
Cranmer,Lee D
Cancer Center Division
ImClone Systems Corporation
A Two-Cohort, Open-Label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination with Tratuzumab and Vinor...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
Evaluation of a Novel Circulating Microvesicle-Based Multi-analyte Assay for the Detection of Prostate Cancer in Men with Elevated Risk for ...
Sokoloff,Mitchell H
Cancer Center Division
Caris Life Sciences
Development of an Automated In Situ Test to Perform Molecular Sub-Classification of Prostate Cancer in Standard Prostate Biopsies
Sokoloff,Mitchell H
Cancer Center Division
Ventana Medical Systems, Inc.
Molecular mechanisms of centrosome amplification in cancer cells
Rogers,Gregory C
Cancer Center Division
Arizona Biomedical Research Commission
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy (Proclaim)
Jeter,Joanne M
Cancer Center Division
Prometheus Labs
Multi-Modality Imaging of Window Chambers
Gmitro,Arthur F
Cancer Center Division
Arizona Biomedical Research Commission
Further Investigation of CFZ anti-tumor activity in SCLC in vitro and in vivo models
Garland,Linda L
Cancer Center Division
Onyx Pharmaceuticals
A Randomised Multicenter, Phase III Open-Label Study of the Efficacy and Safety of Trastuzmab-MCC-DM1 vs. Capecitabine + Lapatinib in Patients with...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
Detecting inherited DNA-repair gene mutations in women with strong family histories of breast cancer
Laukaitis,Christina M
Cancer Center Division
Phi Beta Psi Sorority
Southwest Oncology Group Operations Office Grant
Alberts,David S
Cancer Center Division
University of Michigan
An Automated Karyometric Assay to Predict Response to Drugs that Reduce the Risk of Breast Cancer
Frank,Denise H
Cancer Center Division
Vala Sciences, Incorporated
New Combination Therapies for Advanced Prostate Cancer Based on the Radiosensitizing Potential of 5-Azacytidine
Weterings,Eric
Cancer Center Division
United States Army Medical Research and Material Command
Southwest Oncology Group Operations Office Grant
Krouse,Robert S
Cancer Center Division
University of Michigan
Public Health Surveillance of the Prevention of Complications of Bleeding and Clotting Disorders
Stopeck,Alison T
Cancer Center Division
University of Colorado
A Phase II, Open-label, Multicenter Study to Evaluate the Antitumor Efficacy of CO-1.01 for Infusion as Second-Line Therapy for Gemcitabine...
Dragovich,Tomislav
Cancer Center Division
Clovis Oncology, Incorporated
An open label, multi-center, phase 3 study with corresponding blinded image to determine the efficacy and safety of a single intravenous injection ..
Kuo,Phillip H
Cancer Center Division
Bayer Healthcare Pharmaceuticals Incorportated
Lymphoma Research Foundation Clinical Career Development Award
Schatz,Jonathan H
Cancer Center Division
Lymphoma Research Foundation
Evaluating the Role of Mitochondrial ROS in SCC Cell Proliferation and Migration using Cybrid Model
Jandova,Jana
Cancer Center Division
Dermatology Foundation

Pages

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona